4.5 Article

Synovial fibroblasts promote immunoglobulin class switching by a mechanism involving BAFF

期刊

EUROPEAN JOURNAL OF IMMUNOLOGY
卷 41, 期 7, 页码 2113-2122

出版社

WILEY-BLACKWELL
DOI: 10.1002/eji.201041194

关键词

BAFF; Class switching; Rheumatoid arthritis; Synoviocytes

资金

  1. Universite de Strasbourg (UdS)
  2. Centre National de la Recherche Scientifique (CNRS)

向作者/读者索取更多资源

Fibroblast-like synoviocytes (FLSs) are important actors in rheumatoid arthritis (RA) pathogenesis. The autoimmune nature of RA is attributed to autoantibody production, which confers to B cells a predominant role in RA. Several arguments support an induction of class switch recombination (CSR) in RA synovium, causing-in conjunction with somatic hypermutation-the production of potentially pathogenic IgG. To determine whether RA FLSs can directly promote CSR and to analyze the role of external factors like TLR signals and BAFF (B cell activating factor) family cytokines in this FLS-B cell crosstalk, we performed cocultures of blood B cells (from normal individuals or RA patients) with RA FLSs and analyzed CSR induction by quantification of AICDA (encoding activation-induced cytidine deaminase, AID) and switch circular transcripts expression, and IgG secretion. RA FLSs-and to a lesser extent osteoarthritis or control FLSs-promoted CSR, and TLR3 stimulation potentialized it. In addition, induction of CSR by RA FLSs was totally dependent on cell-cell contact in basal conditions, and partially dependent in the case of TLR3 stimulation. Finally, we showed that the mechanism by which RA FLSs induce CSR is mostly BAFF-dependent. Our results support the hypothesis that CSR can be induced outside the ectopic lymphoid structures in RA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Dermatology

The history of lupus throughout the ages

Renaud Felten, Dan Lipsker, Jean Sibilia, Francois Chasset, Laurent Arnaud

Summary: The term lupus has been used since the Middle Ages to refer to several diseases characterized by ulcerous lesions. In the 19th century, a distinction between different types of lupus emerged, and the systemic nature of the disease was recognized. Modern treatments such as glucocorticoids, hydroxychloroquine, and immunosuppressive agents emerged in the second half of the 20th century. In the 21st century, there has been a deeper understanding of the disease's pathogenesis and the development of biologic and targeted treatments.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Article Medicine, General & Internal

And if we had to do it all over again, would we send medical students to the emergency departments during a pandemic? Lessons learned from the COVID-19 outbreak

Thierry Pelaccia, Jean Sibilia, Elodie Fels, Lucas Gauer, Audrey Musanda, Francois Severac, Milena Abbiati

Summary: The COVID-19 pandemic has led to increased staffing needs in emergency departments, sparking debates on whether medical students should assist. A study conducted at Strasbourg Medical School found that anxiety levels among medical students were higher in 2020 compared to 2018, especially for those who chose not to return to clinical settings. Gender and perceived clinical activity personal conditions were identified as main factors associated with anxiety, while working in clinical settings during the outbreak was not a risk factor for anxiety, suggesting it as an active coping strategy.

INTERNAL AND EMERGENCY MEDICINE (2021)

Article Rheumatology

Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments

Marc Scherlinger, Johanna Lutz, Gael Galli, Christophe Richez, Jacques-Eric Gottenberg, Jean Sibilia, Laurent Arnaud, Patrick Blanco, Thierry Schaeverbeke, Emmanuel Chatelus, Marie-Elise Truchetet

Summary: This study found significant differences in clinical characteristics and prognosis in patients with systemic sclerosis who have concomitant autoimmune diseases. Patients with overlap SgS/SSc had a higher risk of mortality, while those with RA/SSc received more medication treatments.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)

Article Rheumatology

Significance of Sjogren's syndrome and anti-cN1A antibody in myositis patients

Dan Levy, Benoit Nespola, Margherita Giannini, Renaud Felten, Francois Severac, Coralie Varoquier, Marina Rinagel, Anne-Sophie Korganow, Thierry Martin, Vincent Poindron, Francois Maurier, Haitham Chereih, Bastien Bouldoires, Baptiste Hervier, Cedric Lenormand, Emmanuel Chatelus, Bernard Geny, Jean Sibilia, Laurent Arnaud, Jacques-Eric Gottenberg, Alain Meyer

Summary: In myositis patients, Sjogren's syndrome is associated with inclusion body myositis and anti-cN1A antibodies, independently of the IBM diagnosis. As a consequence, anti-cN1A has limited specificity for IBM in myositis patients with Sjogren's syndrome.

RHEUMATOLOGY (2022)

Letter Rheumatology

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Renaud Felten, Pierre-Marie Duret, Elodie Bauer, Nathanael Sedmak, Julien H. Djossou, Massiva Bensalem, Marc Ardizzone, Marion Geoffroy, Angelique Fan, Marion Couderc, Jean Hugues Salmon, Laurent Messer, Rose-Marie Javier, Alain Meyer, Emmanuel Chatelus, Christelle Sordet, Luc Pijnenburg, Jeremy Fort, Marina Rinagel, Julia Walther, Cassandre Fabre, Laurent Arnaud, Jean Sibilia, Nicolas Meyer, Francis Berenbaum, Isabelle Chary-Valckenaere, Martin Soubrier, Jeremie Sellam, Jacques-Eric Gottenberg

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

L. Widawski, T. Fabacher, L. Spielmann, J. E. Gottenberg, J. Sibilia, P. M. Duret, L. Messer, R. Felten

Summary: This study aimed to investigate the effects of hyperuricemia on the clinical presentation, severity, and associated comorbidities of psoriatic arthritis (PsA). The results showed that patients with hyperuricemic PsA had a higher prevalence of male gender, higher body mass index, and more comorbidities compared to patients with normal uric acid levels. Hyperuricemic PsA was associated with older age at onset, more polyarticular and destructive joint involvement. Additionally, hyperuricemic PsA patients had a poorer response to treatment and more peripheral joint damage than normo-uricemic patients.

CLINICAL RHEUMATOLOGY (2022)

Article Cell Biology

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

Raphael Carapito, Richard Li, Julie Helms, Christine Carapito, Sharvari Gujja, Veronique Rolli, Raony Guimaraes, Jose Malagon-Lopez, Perrine Spinnhirny, Alexandre Lederle, Razieh Mohseninia, Aurelie Hirschler, Leslie Muller, Paul Bastard, Adrian Gervais, Qian Zhang, Francois Danion, Yvon Ruch, Maleka Schenck, Olivier Collange, Thien-Nga Chamaraux-Tran, Anne Molitor, Angelique Pichot, Alice Bernard, Ouria Tahar, Sabrina Bibi-Triki, Haiguo Wu, Nicodeme Paul, Sylvain Mayeur, Annabel Larnicol, Geraldine Laumond, Julia Frappier, Sylvie Schmidt, Antoine Hanauer, Cecile Macquin, Tristan Stemmelen, Michael Simons, Xavier Mariette, Olivier Hermine, Samira Fafi-Kremer, Bernard Goichot, Bernard Drenou, Khaldoun Kuteifan, Julien Pottecher, Paul-Michel Mertes, Shweta Kailasan, M. Javad Aman, Elisa Pin, Peter Nilsson, Anne Thomas, Alain Viari, Damien Sanlaville, Francis Schneider, Jean Sibilia, Pierre-Louis Tharaux, Jean-Laurent Casanova, Yves Hansmann, Daniel Lidar, Mirjana Radosavljevic, Jeffrey R. Gulcher, Ferhat Meziani, Christiane Moog, Thomas W. Chittenden, Seiamak Bahram

Summary: In this study, multi-omics analysis and artificial intelligence were used to examine the differences in biological factors between critical and non-critical COVID-19 patients in a young and otherwise healthy cohort. The study identified ADAM9 as a driver of disease severity and a potential therapeutic target.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Oncology

CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells

Isis Benoit-Lizon, Elise Jacquin, Thaiz Rivera Vargas, Corentin Richard, Aurelie Roussey, Ludivine Dal Zuffo, Tiffany Martin, Andrea Melis, Daria Vinokurova, Sayyed Hamed Shahoei, Alvaro Baeza Garcia, Cassandre Pignol, Stephane Giorgiutti, Raphael Carapito, Romain Boidot, Frederique Vegran, Richard A. Flavell, Bernhard Ryffel, Eric R. Nelson, Pauline Soulas-Sprauel, Toby Lawrence, Lionel Apetoh

Summary: Activation of STING signaling enhances the differentiation and antitumor functions of T(H)1 and T(H)9 cells by increasing their production of IFN-gamma and interleukin-9, respectively. IRF3 and IFNARs are required for the enhancement of T(H)1 cell differentiation, while mTOR signaling is implicated in T(H)9 cell differentiation in response to STING activation. STING activation boosts the antitumor activity of T(H)1 and T(H)9 cells through their cytokine production, and enhances the efficacy of T(H)9 cells in adoptive transfer against melanoma.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Immunology

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

Marc Scherlinger, Luc Pijnenburg, Emmanuel Chatelus, Laurent Arnaud, Jacques-Eric Gottenberg, Jean Sibilia, Renaud Felten

Summary: This study suggests that SARS-CoV-2 vaccination is well tolerated and immunogenic in the majority of patients with long-COVID or post-acute sequelae of COVID-19 (PASC). Disseminating these reassuring data might prove crucial to increasing vaccine coverage in patients with PASC.

VACCINES (2022)

Editorial Material Rheumatology

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab

Renaud Felten, Floriane Gallais, Cedric Schleiss, Emmanuel Chatelus, Rose-Marie Javier, Luc Pijnenburg, Christelle Sordet, Jean Sibilia, Laurent Arnaud, Samira Fafi-Kremer, Jacques-Eric Gottenberg

LANCET RHEUMATOLOGY (2022)

Editorial Material Rheumatology

Tissue microbiota: A 'secondary-self', first target of autoimmunity?

Jean-Marie Berthelot, Frederic Liote, Jean Sibilia

JOINT BONE SPINE (2022)

Letter Immunology

Complex Allele with Additive Gain-of-Function STING1 Variants in a Patient with Cavitating Lung Lesions and Aspergillosis

Aurelien Guffroy, Yannick Dieudonne, Vincent Gies, Francois Danion

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Review Rheumatology

Age-related mechanisms in the context of rheumatic disease

Ghada Alsaleh, Felix C. Richter, Anna K. Simon

Summary: This review discusses the involvement of ageing hallmarks in rheumatic diseases and suggests that these chronic conditions can be considered as diseases of premature or accelerated ageing. It also proposes that targeting age-related pathways may provide new therapeutic interventions for patients with rheumatic diseases.

NATURE REVIEWS RHEUMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10

Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, Klara Piletic, Ghada Alsaleh, Ramona Zummach, Julia Hecker, Mathilde Pohin, Nicholas Ilott, Irina Guschina, Sarah Karin Wideman, Errin Johnson, Mariana Borsa, Paula Hahn, Christophe Morriseau, Bruce D. Hammock, Henk Simon Schipper, Claire M. Edwards, Rudolf Zechner, Britta Siegmund, Carl Weidinger, Nils Helge Schebb, Fiona Powrie, Anna Katharina Simon

Summary: Lipids play a major role in inflammatory diseases through altering inflammatory cell functions. Autophagy, a lysosomal degradation pathway, is found to regulate lipid availability, which affects inflammation. Loss of autophagy gene Atg7 in adipocytes exacerbates intestinal inflammation by causing an imbalance of oxylipins, reducing IL-10 secretion, and exacerbating intestinal inflammation through the cytochrome P450-EPHX pathway.

EMBO JOURNAL (2023)

Article Rheumatology

Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey

Arthur Petitdemange, Renaud Felten, Jean Sibilia, Thierry Martin, Laurent Arnaud

Summary: The study reveals significant heterogeneity in antimalarial agent prescription among physicians treating lupus, with key unmet needs identified regarding this treatment approach. This highlights the importance of developing more comprehensive recommendations and promoting dissemination among healthcare providers.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

暂无数据